A Cost-utility Analysis of Ferric Derisomaltose versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China

F Zhang, A Shen, Waqas Ahmed, Richard F. Pollock
doi: https://doi.org/10.1101/2024.07.11.24310267

Article Information

doi 
https://doi.org/10.1101/2024.07.11.24310267
History 
  • July 11, 2024.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. F Zhanga,
  2. A Shenb,
  3. Waqas Ahmedc and
  4. Richard F. Pollockc,*
  1. aChinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, Tianjin, China
  2. bThe First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei, China
  3. cCovalence Research Ltd, Harpenden, UK
  1. ↵*Corresponding author: Name: Richard F. Pollock, Postal address: Covalence Research Ltd, Rivers Lodge, West Common, Harpenden, AL5 2JD, United Kingdom, E-mail: pollock{at}covalence-research.com, Phone: +44 (0) 20 8638 6525
Back to top
Posted July 11, 2024.
Download PDF
Data/Code
Email
A Cost-utility Analysis of Ferric Derisomaltose versus Ferric Carboxymaltose in Patients with Iron Deficiency Anemia in China
F Zhang, A Shen, Waqas Ahmed, Richard F. Pollock
medRxiv 2024.07.11.24310267; doi: https://doi.org/10.1101/2024.07.11.24310267
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area